Profil bibliographique

Emmett V. Schmidt

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

240Publications signalées

12265Citations signalées

5Affiliations récentes

Les institutions déclarées

Merck & Co., Inc., Rahway, NJ, USA (United States)Massachusetts General Hospital National Human Genome Research Institute Cancer Research Center Center for Cancer Research

Les domaines associés

Cancer Immunotherapy and BiomarkersCancer-related Molecular PathwaysCAR-T cell therapy researchCancer Research and TreatmentsEpigenetics and DNA Methylation

Les publications récentes

2023 conference-abstract OpenAlex

First-in-human, phase 1a dose finding of LVGN6051 CD137/4-1BB agonistic antibody with or without pembrolizumab in patients with advanced solid tumors.

Adil Daud, Costantine Albany, Vamsidhar Velcheti, Ralph J. Hauke et autres

us (code pays fourni par la source)

2 citations Journal of Clinical Oncology

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figures 1-4; Supplementary Tables 1 & 2 from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figure Legends from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figures 1-4; Supplementary Tables 1 & 2 from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figure Legends from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Tables S1-S3, Figures S1-S5 from SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Table S4 from SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Table S4 from SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Tables S1-S3, Figures S1-S5 from SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck, Joseph A. Reddy et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.